![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » OSI PHARMA LOOKING FOR JAPAN TARCEVA OK
OSI PHARMA LOOKING FOR JAPAN TARCEVA OK
April 17, 2006
OSI Pharmaceuticals Inc. said Monday that its international
marketing partner for the cancer drug Tarceva submitted a marketing application
to get the drug approved in Japan.
The
Houston Chronicle
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct